Hello, Sign in
My Account
My Account
New customer? Start here
| Catalog # | Availability | Size | Quantity | Unit Price | Save For Later Wish List | |
|---|---|---|---|---|---|---|
| ABM0400-10 | 7 days | 10 µg | $120.00 |
Select product before adding to cart
|
||
| ABM0400-50 | 7 days | 50 µg | $290.00 | |||
| ABM0400-1 | 7 days | 1 mg | $2,160.00 |
Product Overview | |
| Name | Influenza-A H1N1 Antibody |
|---|---|
| Description | |
| Influenza-A Hemagglutinin H1N1, Mouse Antibody | |
| Immunogen | |
| Anti-human Influenza-A H3N2 mAb, is derived from hybridization of mouse FO myeloma cells with spleen cells from BALB/c mice immunized with recombinant human H3N2/HA1 amino acids 17-345 purified from Baculovirus. | |
| Introduction | |
| H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin(H) and neuraminidase(N). H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, and influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. | |
| Formulation | |
| 1mg/ml containing PBS, pH-7.4, 0.02% Sodium Azide and 10% glycerol. | |
| Applications | |
| Influenza-A H3N2 antibody has been tested by ELISA, Western blot analysis to assure specificity and reactivity. Since application varies, however, each investigation should be titrated by the reagent to obtain optimal results. | |
| Type | |
| Mouse Anti Human Monoclonal. | |
| Clone | |
| PAT1B7AT. | |
| Ig Subclass | |
| Mouse IgG1 heavy chain and k light chain. | |
| Purification Method | |
| H3N2/HA1 antibody was purified from mouse ascitic fluids by protein-G affinity chromatography. | |
| Storage Procedures | |
| For periods up to 1 month store at 4°C, for longer periods of time, store at -20°C. Prevent freeze thaw cycles. | |
| Stability / Shelf Life | |
| 12 months at -20°C. 1 month at 4°C. | |
| References | |
| Title: Transcutaneous Anti-Influenza Vaccination Promotes Both CD4 and CD8 T Cell Immune Responses in Humans Publications: The Journal of Immunology 180.3 (2008): 1482-1489. Link: Influenza-A H3N2 Antibody prospec publication | |
| Precautions | |
| Influenza-A H1N1 Antibody is for research use only and not for use in diagnostic or therapeutic procedures. | |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from ADMEbio to advance their research.
Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
Thank you,
ADMEbio Team
ADMEbio welcomes feedback from our customers.
Thank you,
ADMEbio Team
